ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,543.06
0.38%
Dow Jones
40,999.37
0.38%
US Dollar vs MXN
18.48635
-0.84%
Brent Oil
81.295
-0.26%
Bitcoin
64,577.17
-0.03%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Adaptive Biotechnologies Corporation (ADPT) Cotización

Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation (ADPT)

Adaptogenics Health Corp
4.55
-0.05
(-1.09%)
Cerrado 31 Julio 3:00PM
Delayed by 15 minutes
4.54
-0.01
( -0.22% )
Pre Mercado: 8:07AM
Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Estadísticas y detalles clave

Último Precio
4.54
Postura de Compra
4.50
Postura de Venta
4.56
Volume Operado de la Acción
1,103
0.00 Rango del Día 0.00
2.28 Rango de 52 semanas 8.39
Capitalización de Mercado [m]
669.052M
Precio Anterior
4.55
Precio de Apertura
-
Hora
500
@
4.54
(formt)
Última hora de negociación
07:59:54
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
1,450,917
Acciones en circulación
147,368,324
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-2.98
Beneficio por acción (BPA)
-1.53
turnover
170.28M
Beneficio neto
-225.25M

Acerca de Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for... Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers. Mostrar más

Sector
Biological Pds,ex Diagnstics
Industria
Biological Pds,ex Diagnstics
Sitio web
www.adaptivebiotech.com
Sede
Olympia, Washington, USA
Fundado
1970
Adaptive Biotechnologies Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ADPT. The last closing price for Adaptive Biotechnologies was US$4.55. Over the last year, Adaptive Biotechnologies shares have traded in a share price range of US$ 2.28 to US$ 8.39.

Adaptive Biotechnologies currently has 147,368,324 shares in issue. The market capitalisation of Adaptive Biotechnologies is US$670.53 million. Adaptive Biotechnologies has a price to earnings ratio (PE ratio) of -2.98.

ADPT Últimas noticias

Más noticias

Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024

SEATTLE, July 11, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...

11 Julio 2024
GlobeNewswire Inc.

Form 8-K - Current report

11 Junio 2024
Edgar (US Regulatory)

Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress

SEATTLE, May 31, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...

31 Mayo 2024
GlobeNewswire Inc.

Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

SEATTLE, May 29, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...

29 Mayo 2024
GlobeNewswire Inc.

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

24 Mayo 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

17 Mayo 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

07 Mayo 2024
Edgar (US Regulatory)

Form 8-K - Current report

07 Mayo 2024
Edgar (US Regulatory)

Adaptive Biotechnologies Reports First Quarter 2024 Financial Results

SEATTLE, May 07, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the...

07 Mayo 2024
GlobeNewswire Inc.

Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024

SEATTLE, April 17, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...

17 Abril 2024
GlobeNewswire Inc.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.358.353221957044.194.814.1613842294.49347302CS
41.1634.31952662723.384.813.3313039454.15478232CS
121.3441.8753.24.812.9914509173.71187549CS
260.8422.70270270273.74.812.2815773953.4223101CS
52-3.76-45.30120481938.38.392.2815194634.19809428CS
156-32.46-87.729729729737402.2812233379.03665493CS
260-34.01-88.223086900138.5571.252.28109147719.18932805CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
AAGRAfrican Agriculture Holdings Inc
US$ 0.1542
(0.00%)
12.78k
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 62.17
(0.00%)
0
AADIAadi Bioscience Inc
US$ 1.55
(0.00%)
12
AACIArmada Acquisition Corporation I
US$ 8.29
(0.00%)
6
AACGATA Creativity Global
US$ 0.656
(0.00%)
72
AAGRAfrican Agriculture Holdings Inc
US$ 0.1542
(0.00%)
12.78k
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 62.17
(0.00%)
0
AADIAadi Bioscience Inc
US$ 1.55
(0.00%)
12
AACIArmada Acquisition Corporation I
US$ 8.29
(0.00%)
6
AACGATA Creativity Global
US$ 0.656
(0.00%)
72
HUGEFSD Pharma Inc
US$ 0.101
(0.00%)
50.93M
RDHLRedhill Biopharma Ltd
US$ 0.3841
(0.00%)
49.46M
BBLGBone Biologics Corporation
US$ 2.16
(0.00%)
25.91M
RCMR1 RCM Inc
US$ 13.95
(0.00%)
16.87M
NVDANVIDIA Corporation
US$ 117.02
(0.00%)
15.49M

Discusión

Ver feed completo
scooby5 scooby5 3 minutos hace
Will the shorts finally bail out?
IDCC
TheFinalCD TheFinalCD 3 minutos hace
29.30 https://x.com/READY_2_PROFIT/status/1819001515891102144
RBLX
glenn1919 glenn1919 4 minutos hace
LUMN.......IMNN.........BFI........https://stockcharts.com/h-sc/ui?s=LUMN&p=W&b=5&g=0&id=p84354014936
https://stockcharts.com/h-sc/ui?s=BFI&p=W&b=5&g=0&id=p84354014936
https://stockcharts.com/h-sc/ui?s=IMNN&p=W&b=5&g=0&id=p84354014936
BFI IMNN LUMN
Louied91 Louied91 4 minutos hace
$INBS Intelligent Bio Solutions Partners with CenExel to Conduct Clinical Study as Part of FDA 510(k) Pathway

https://www.globenewswire.com/news-release/2024/08/01/2922771/0/en/Intelligent-Bio-Solutions-Partners-with-CenExel-to-Conduct-Clinical-Study-as-Part-of-FDA-510-k-Pathway.html
INBS
blackhawks blackhawks 4 minutos hace
Like the Lipid Blood Panel destroying full stick of butter we see in the recipes from time to time.
Ricorich Ricorich 4 minutos hace
We're about to enter supernova mode!
https://images.app.goo.gl/CDzdthQ6W7PL51uBA
HIRU
Nebuchadnezzar Nebuchadnezzar 4 minutos hace
another bad qtr

they will file for BK
WW
straightword straightword 4 minutos hace
Ha ha ha. What happened to the big "settlement" from Amazon that was a "sure thing" that was supposed to happen last fall? LMAO!!
VPLM
KeepItRealistic KeepItRealistic 4 minutos hace
I am possibly older !

All good buddy
BURUD
MetaMonster MetaMonster 4 minutos hace
Everyone here is broke / bankrupt /evicted individuals who lost it all with this scumbag CEO RIP RNVA
RNVA
iamthe walrus iamthe walrus 5 minutos hace
Perhaps they did not close on the final date July 31st as it was the last day of the quarter but instead are closing it out in this quarter which starts today and then would be a new consolidated company starting in the new quarter upon finalizing the close in this new quarter today or tommorrow ??
CRTG
Jack_of_All_Trades Jack_of_All_Trades 5 minutos hace
HIRU copper could come quickly...
HIRU
Chipaway Chipaway 5 minutos hace
Still 497 followers here which is encouraging as well.
BLEG
Neffets Luap Neffets Luap 5 minutos hace
Primed and ready....news is brewing.....can feel it!
FOXO
cpeter7 cpeter7 5 minutos hace
I look it as Veritone needs Gus to help manage those contracts. I think Gus would have plenty of opportunities and wouldn't attach himself to a company that's staring bankruptcy in the face unless there is something good going on.
VERI
Huggy Bear Huggy Bear 5 minutos hace
Hilarious.
SPZI
hnbadger1 hnbadger1 5 minutos hace
Posted by TTTav66 on stock Twts-

Qynapse

Positive reduction in #QyScore® atrophy measures in an early Alzheimer's
aisease pooulation.
wynapse is attending #hAle44 in Phlladelpnia and we are looking forward to seeing many of you there for some groundbreakin
AVXL
oilin07 oilin07 5 minutos hace
Pennies coming
BLLB
Maxthedog Maxthedog 5 minutos hace
Zack’s had put an outperform rating but does anyone know at what price range ?
ELTP
$treet Trader $treet Trader 5 minutos hace
Good morning A$ & LD
lowfloatmaster lowfloatmaster 5 minutos hace
$TMEF HUGE NEWS ON BEST SS OTC OUT THERE. UNDER RADAR. 5K AT DTC STOCKS 2 BUCKS..https://www.otcmarkets.com/stock/TMEF/news/story?e&id=2935143
TMEF
Paulness Paulness 6 minutos hace
NEWS -- Lineage Cell Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024

https://media.zenfs.com/en/business-wire.com/82d644dfe6fe243e6c45ea18b24d1083

CARLSBAD, Calif., August 01, 2024--(BUSINESS WIRE)--Lineage Cell
LCTX
Chartmaster Chartmaster 6 minutos hace
IDVV Corporate UpdatePress Release | 08/01/2024

CARLSBAD, CA, August 1, 2024 (OTCMARKETS) -- International Endeavors Corp. ("IEC") (OTC PINK: IDVV), a technology holdings company announced the following statement.

The company WITech division has finalized its agreement
IDVV
$treet Trader $treet Trader 6 minutos hace
Good morning .0001ers
Hercules1 Hercules1 6 minutos hace
more updates are arriving today.
HIRU

Su Consulta Reciente

NASDAQ
ADPT
Adaptive Biotechnologies
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados